HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.

Abstract
Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-beta(2)) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-beta(2) inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-beta(2)-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-beta(2) and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-beta(2) did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-beta(2) expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-beta(2) gene promoter in esophageal cancer cells. Transfection of RAR-beta(2) expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-beta(2)-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-beta(2) results in COX-2 induction and restoration of RAR-beta(2) expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-beta(2) plays an important role in suppressing esophageal carcinogenesis.
AuthorsShumei Song, Scott M Lippman, Yiyu Zou, Xiaofeng Ye, Jaffer A Ajani, Xiao-Chun Xu
JournalOncogene (Oncogene) Vol. 24 Issue 56 Pg. 8268-76 (Dec 15 2005) ISSN: 0950-9232 [Print] England
PMID16170369 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightOncogene (2005) 24, 8268-8276. doi:10.1038/sj.onc.1208992; published online 19 September 2005.
Chemical References
  • Butadienes
  • Nitriles
  • Receptors, Retinoic Acid
  • Transcription Factor AP-1
  • U 0126
  • retinoic acid receptor beta
  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
  • Cyclooxygenase 2
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
Topics
  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide (pharmacology)
  • Animals
  • Butadienes (pharmacology)
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Cyclooxygenase 2 (biosynthesis, genetics)
  • DNA Methylation (drug effects)
  • Enzyme Induction (drug effects, genetics)
  • Extracellular Signal-Regulated MAP Kinases (antagonists & inhibitors, biosynthesis, genetics)
  • JNK Mitogen-Activated Protein Kinases (biosynthesis, genetics)
  • Mice
  • Mice, Nude
  • Multigene Family (physiology)
  • Nitriles (pharmacology)
  • Phosphorylation
  • Promoter Regions, Genetic (drug effects)
  • Receptors, Retinoic Acid (antagonists & inhibitors, biosynthesis, physiology)
  • Transcription Factor AP-1 (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: